Respiratory Health
Swine respiratory diseases can have a huge impact on your herd’s daily performance as animals redirect energy to the immune system instead of growth.
Take control with Merck Animal Health respiratory solutions.
Shown effective for the vaccination of healthy swine 3 weeks of age or older against disease caused by Porcine Circovirus Types 2a and 2d, Mycoplasma hyopneumoniae, and Lawsonia intracellularis. Duration of immunity for Porcine Circovirus Type 2d is at least 16 weeks, and for Mycoplasma hyopneumoniae is at least 10 weeks. Duration of immunity for ileitis due to Lawsonia intracellularis is at least 20 weeks. Duration of immunity for Porcine Circovirus Type 2a has not been established.
An aid in the prevention of viremia, aid in the reduction of virus shedding and aid in the reduction of lymphoid infection caused by porcine circovirus Type 2. Convenient one- or two-dose options (2 mL once or 1 mL twice, see complete label instructions). The only PCV2 vaccine approved for use in pigs as early as 3 days of age (two-dose option).
An aid in the prevention of viremia, aid in the reduction of virus shedding, aid in the reduction of lymphoid infection caused by porcine circovirus Type 2, and an aid in the reduction of lung lesions caused by Mycoplasma hyopneumoniae. Convenient one- or two-dose options (2 mL once or 1 mL twice, see complete label instructions). The only PCV2 vaccine approved for use in pigs as early as 3 days of age (two-dose option).
An aid in the prevention of pneumonia caused by Mycoplasma hyopneumoniae infection in swine. Convenient one- or two-dose options (2 mL once or 1 mL twice, see complete label instructions) for one-dose and two-dose programs (see complete label instructions). Unique patented dual-emulsion adjuvant. Up to four months DOI with a single shot.
For use in healthy swine as an aid in the prevention of pneumonia caused by Mycoplasma hyopneumoniae. This product contains an inactivated culture in Microsol Diluvac Forte® adjuvant. Aids in prevention of enzootic mycoplasma pneumonia for up to 6 months.
This product has been shown to be effective for the vaccination of healthy swine 3 weeks of age or older against respiratory disease caused by Porcine Reproductive and Respiratory Syndrome (PRRS) virus and female breeding age swine against reproductive disease caused by PRRS virus.
Sequivity® IAV-S NA has been shown to be effective for the vaccination of healthy swine, 3 days of age or older, against influenza strains H1N1, H1N2 and H3N2. A duration of immunity of at least 12 weeks has been established against a 2019 H1N1 subtype.